semaglutide and suboxone Nov 13, 2025 FDA Approves Oral Semaglutide as

Enrollment was completed in March 2026

Purpose of Review Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are used by increasing numbers of patients, but may adversely affect the safety of endoscopic procedures, due to their association with decreased gastrointestinal motility

GLP-1 medication helps break weight loss plateaus by reducing hunger and boosting results

See if you qualify for compensation and how to file.

Figure 1 shows some key examples of the types of digital solutions currently being used for weight management, including the top-rated apps for weight disorders according to IQVIAs AppScript Digital Medicine Database, and insights from in-depth interviews that IQVIA has conducted with people living with obesity in the US, UK and Spain on how digital solutions are currently being used (IQVIAs Obesity Patient Voice Book of Insights2).

This has raised concerns about their impact on cancer risk, spurring extensive research